EP2026657A4 - Composition anticancéreuse et sa méthode d'utilisation - Google Patents

Composition anticancéreuse et sa méthode d'utilisation

Info

Publication number
EP2026657A4
EP2026657A4 EP07784125A EP07784125A EP2026657A4 EP 2026657 A4 EP2026657 A4 EP 2026657A4 EP 07784125 A EP07784125 A EP 07784125A EP 07784125 A EP07784125 A EP 07784125A EP 2026657 A4 EP2026657 A4 EP 2026657A4
Authority
EP
European Patent Office
Prior art keywords
same
cancer composition
cancer
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP07784125A
Other languages
German (de)
English (en)
Other versions
EP2026657A1 (fr
Inventor
Brian C Giles
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PHARMAIONIX Inc
Original Assignee
PHARMAIONIX Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PHARMAIONIX Inc filed Critical PHARMAIONIX Inc
Publication of EP2026657A1 publication Critical patent/EP2026657A1/fr
Publication of EP2026657A4 publication Critical patent/EP2026657A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/243Platinum; Compounds thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
EP07784125A 2006-05-24 2007-05-24 Composition anticancéreuse et sa méthode d'utilisation Withdrawn EP2026657A4 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US80808106P 2006-05-24 2006-05-24
US80998406P 2006-06-01 2006-06-01
US87985707P 2007-01-11 2007-01-11
PCT/US2007/069695 WO2007140280A1 (fr) 2006-05-24 2007-05-24 Composition anticancéreuse et sa méthode d'utilisation

Publications (2)

Publication Number Publication Date
EP2026657A1 EP2026657A1 (fr) 2009-02-25
EP2026657A4 true EP2026657A4 (fr) 2009-12-09

Family

ID=41278173

Family Applications (1)

Application Number Title Priority Date Filing Date
EP07784125A Withdrawn EP2026657A4 (fr) 2006-05-24 2007-05-24 Composition anticancéreuse et sa méthode d'utilisation

Country Status (2)

Country Link
EP (1) EP2026657A4 (fr)
WO (1) WO2007140280A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009076553A1 (fr) * 2007-12-11 2009-06-18 Monroe Stephen H Composition de solution tampon aqueuse pour le traitement d'un environnement cellulaire et de canaux ioniques et procédés d'utilisation de celle-ci
JP2021513556A (ja) * 2017-12-21 2021-05-27 ザ アンジオジェネシス ファウンデーション 新形成を治療するための組成物および方法
WO2019240706A2 (fr) * 2018-01-26 2019-12-19 Demir Caner Composé de dichloro-acétate de césium destiné à être utilisé dans le traitement du cancer
US11286236B2 (en) 2018-06-05 2022-03-29 Vector Vitale Ip Llc Compound, agent and composition for the suppression of cancer growth
AU2019475409B2 (en) 2019-11-22 2024-10-17 Vector Vitale Ip Llc Method of preventing the development of melanoma
CN115666593B (zh) * 2020-05-21 2025-11-25 国立大学法人大阪大学 上皮癌治疗药
CN113303476B (zh) * 2021-04-23 2022-10-04 中山大学 铷盐及铷盐溶液在制备延长寿命和/或抗衰老产品中的应用

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994003189A1 (fr) * 1992-07-31 1994-02-17 John Lai Methodes utilisant des ions cesium therapeutiques
WO2001015745A1 (fr) * 1999-08-31 2001-03-08 Giles Brian C Procede et formule destines a la remission des tumeurs et a la suppression du cancer
KR20020025109A (ko) * 2002-01-28 2002-04-03 박동인 함초연고
US20050244344A1 (en) * 2004-04-12 2005-11-03 Brian Giles Compositions for oral hygiene and method for using same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040253323A1 (en) * 2003-06-11 2004-12-16 Giles Brian C. Ionic cancer therapy and methods for using same in the treatment of tumors and metastasis
US20060078541A1 (en) * 2004-10-01 2006-04-13 Giles Brian C Method and formula for stem cells' stimulation, targeting release, trafficking and homing

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994003189A1 (fr) * 1992-07-31 1994-02-17 John Lai Methodes utilisant des ions cesium therapeutiques
WO2001015745A1 (fr) * 1999-08-31 2001-03-08 Giles Brian C Procede et formule destines a la remission des tumeurs et a la suppression du cancer
KR20020025109A (ko) * 2002-01-28 2002-04-03 박동인 함초연고
US20050244344A1 (en) * 2004-04-12 2005-11-03 Brian Giles Compositions for oral hygiene and method for using same

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2007140280A1 *

Also Published As

Publication number Publication date
EP2026657A1 (fr) 2009-02-25
WO2007140280A1 (fr) 2007-12-06

Similar Documents

Publication Publication Date Title
IL195619A0 (en) Compositions and methods for joininig non-conjoined iumens
AP2942A (en) Compositions and methods for controlling nematodes
GB0709781D0 (en) Composition and method
GB0724967D0 (en) Composition and method
EP2173825A4 (fr) Composition d'encre et son procédé de préparation
GB0525314D0 (en) Method and composition
EP2026657A4 (fr) Composition anticancéreuse et sa méthode d'utilisation
PL2132251T3 (pl) Kompozycja i sposób
EP2065450A4 (fr) Crayon et son procédé de production
EP2067832A4 (fr) Crayon et son procédé de production
SG136084A1 (en) Adhesive composition and method for producing the same
GB0524009D0 (en) Composition and method
GB0625208D0 (en) Composition and method
GB0620930D0 (en) Composition and method for use thereof
GB0607562D0 (en) Method, composition and use
GB0522655D0 (en) Composition and method
GB0600261D0 (en) Composition and method
GB0604315D0 (en) Composition and method
GB0605004D0 (en) Composition and process
GB0607488D0 (en) Composition and process
TWI369180B (en) Corpse-treatment composition and corpse-treatment method
GB0607493D0 (en) Composition and process
GB0621096D0 (en) Composition and method
GB0717401D0 (en) Method and composition
AU2007905485A0 (en) Composition and method

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20081223

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK RS

A4 Supplementary search report drawn up and despatched

Effective date: 20091109

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 35/00 20060101ALI20091103BHEP

Ipc: A61P 31/00 20060101ALI20091103BHEP

Ipc: A61P 29/00 20060101ALI20091103BHEP

Ipc: A61P 17/02 20060101ALI20091103BHEP

Ipc: A61P 17/00 20060101ALI20091103BHEP

Ipc: A61K 45/06 20060101ALI20091103BHEP

Ipc: A61K 33/00 20060101AFI20091103BHEP

17Q First examination report despatched

Effective date: 20100212

DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20120811